Hunan Nucien Pharmaceutical Co., Ltd.

¥6.20As of Sun 8 Nov 2026, 12:00 UTC
SSE:688189Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR (18.28%)
Div yield —
ROE (19.34%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.30
PE TTM —
TSR TTM (32.39%)
Mkt cap ¥1.692B
ROIC (17.69%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.48
4.45%
(20.49%)
Hold 4|11|12|8|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.07
0.08
0.08
(3.54%)
2.43%
13.21%
14.48%
Revenue¥M
205.3
211.3
205.5
206.5
10.90%
14.89%
6.84%
5.65%
Peers (US$253.6M)
Cap (US$)
PE
281.3M
—
275.7M
29.33x
Capital
TTM
5Y
10Y
Leveragex
4.327
2.386
1.125
EBIT/Intx
1.507
0.032
0.032
Own earn%
(25.00)
(36.04)
(36.20)
Sh yield%
30.72
51.07
48.45
Owners
Insiders/Inst%
12.06
82.90
Short interest%
4.46
SBC / revenue%
4.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
13–21
$1 testx
—
Incr. ROIC%
2